5 Best Short Squeeze Stocks To Buy Now

3. Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT)

Number of Hedge Fund Holders: 13

Short Interest: 27.28%

Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) is a New York-based biopharmaceutical firm focusing on the development of treatment for liver diseases. It is placed third on our list of 15 best short squeeze stocks to buy now.

On August 20, investment advisory Goldman Sachs downgraded Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) stock to Sell from Neutral and lowered the price target to $10 from $17, noting the pressures of commercialization on a new drug of the firm. 

Out of the hedge funds being tracked by Insider Monkey, Illinois-based investment firm Deerfield Management is a leading shareholder in Intercept Pharmaceuticals, Inc. (NASDAQ:ICPT) with 57 million shares worth more than $51 million.